John A. Neczesny is on the board of Immune Pharmaceuticals, Inc. and Gemelli Biotech Corp. Mr. Neczesny previously was Managing Director at Oberon Securities LLC, Managing Director at Bear, Stearns & Co., Inc. and Vice President-Corporate Development at Endo Generics Holdings, Inc.

John A. Neczesny received an undergraduate degree from the University of Delaware and an MBA from The Leonard N Stern School of Business.